Two ASX Healthcare Stocks Facing Declines Amid Market Challenges

1 min read | July 24, 2024 02:08 PM AEST | By Team Kalkine Media

Google News:

Two ASX Healthcare Stocks Facing Declines Amid Market Challenges — Image source: shutterstock.com

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

On a challenging Wednesday for the S&P/ASX 200 Index, which sees marginal losses hovering around 7,967.4 points, several stocks stand out for their notable declines. Here’s a closer look at why these healthcare companies are struggling today:

Mesoblast Ltd (ASX:MSB)

Mesoblast is witnessing a 4% decline in its share price, dropping to AU$1.25. The downturn appears to stem from profit-taking activities following a strong performance the previous day, driven by an announcement regarding its Biologics License Application (BLA) resubmission for Ryoncil (remestemcel-L). Despite the positive development of the BLA acceptance by the US FDA for treating children with steroid-refractory acute graft versus host disease, investors may be reacting to the fact that this is not an approval, leading to some market correction.

Telix Pharmaceuticals Ltd (ASX:TLX)

Telix Pharmaceuticals is facing a 6% decrease in its share price, now trading at AU$19.12. Investor sentiment turned cautious after the company successfully priced AU$650 million 2.375% convertible notes due in 2029. While CEO Dr. Christian Behrenbruch emphasised the financing's benefits in providing financial flexibility and strategic execution capability, shareholders may be concerned about potential dilution from the convertible bonds offering.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.